Streetbeat News

Regulatory

CGTX

Trading for CGTX was halted at 6:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:55 am

AMRN

HLS Therapeutics has entered into a Product Listing Agreement with the Province of Alberta for the listing and public reimbursement of Amarin's Vascepa, effective August 1, 2024. Vascepa will be reimbursed for secondary prevention of cardiovascular events in statin-treated patients with established cardiovascular disease and elevated triglycerides.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:50 am

GH

Guardant Health's Shield blood test for colorectal cancer screening has received FDA approval, making it the first blood test approved as a primary screening option for CRC. This approval also meets Medicare coverage requirements, potentially increasing CRC screening rates in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:31 am

VFS

VinFast announced it will restate its unaudited financial statements for Q1 Fiscal 2024. The board concluded that the financial statements for the year ended December 2023 and the quarter ended March should no longer be relied upon.

Portfolio Pulse from charles@benzinga.com

July 29, 2024 | 10:15 am

F

Ford Motor Co. has patented a technology to detect and report speeding drivers. The system can identify speeding vehicles, capture images, and transmit data to law enforcement. This innovation aims to address speeding-related traffic fatalities, which accounted for 29% of all traffic deaths in 2022.

Portfolio Pulse from Anan Ashraf

July 29, 2024 | 10:05 am

NUTX

Nutex Health Inc. (NASDAQ:NUTX) has regained compliance with Nasdaq's minimum bid price requirement following a 1:10 reverse stock split. The company's stock traded above $1.00 per share from July 3, 2024, to July 23, 2024, resolving the prior bid price deficiency.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 9:31 am

LIPO

Lipella Pharmaceuticals has commenced a Phase 2a trial for LP-310, a liposomal-tacrolimus oral rinse formulation, targeting Oral Lichen Planus. The trial has enrolled its first patients and is actively screening more across multiple research sites in the US.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 9:04 am

FFND

TSLA

Tesla shares fell over 8% during the week ending July 26, halting an upward trend. Gary Black's Future Fund LLC reduced its Tesla stake from over 5% to 3.55%. Black outlined conditions for increasing his position, including stabilizing auto gross margins, achieving 25%+ volume growth with sub-$30K EVs, and improving full self-driving technology efficacy. The stock may remain range-bound near $200 without significant catalysts, with potential momentum from the Oct. 10 robotaxi event. Concerns include valuation, reliance on regulatory credits, and potential political risks.

Portfolio Pulse from Shanthi Rexaline

July 29, 2024 | 8:24 am

BTCUSD

Vivek Ramaswamy predicts a 1% boost in Donald Trump's vote share due to his support for Bitcoin and the cryptocurrency industry. Trump made significant pro-crypto promises at the Bitcoin 2024 conference, including firing SEC Chair Gary Gensler and opposing Central Bank Digital Currencies. Bitcoin's price rose 3.49% following these developments.

Portfolio Pulse from Aniket Verma

July 29, 2024 | 6:25 am

SVMH

SRIVARU has received a delisting notification from Nasdaq and plans to appeal the decision.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 5:49 am